Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research
Beatriz Pinto Ribeiro de Araujo, Luiz Silva, Jorge Torresi, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5084-5102
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Mitochondria, energy, and metabolism in neuronal health and disease
Diogo Trigo, Catarina Avelar, Miguel X. Fernandes, et al.
FEBS Letters (2022) Vol. 596, Iss. 9, pp. 1095-1110
Closed Access | Times Cited: 113
Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis
Yujun Zhou, Jingshu Tang, Jiaqi Lan, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 577-597
Open Access | Times Cited: 41
Mitochondrial Dysfunction in Sporadic Amyotrophic Lateral Sclerosis Patients: Insights from High-Resolution Respirometry
Petra Parvanovova, Andrea Evinová, Milan Grofik, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1294-1294
Open Access | Times Cited: 4
Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy
Isabel Lastres‐Becker, Gracia Porras, Marina Arribas-Blázquez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3007-3007
Open Access | Times Cited: 25
Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship
Niccolò Candelise, Illari Salvatori, Silvia Scaricamazza, et al.
Metabolites (2022) Vol. 12, Iss. 3, pp. 233-233
Open Access | Times Cited: 17
SIRTUINS MODULATORS MITIGATE HYPOXIA-INDUCED CELL DEATH DUE TO CHANGES IN HISTONE 3 ACETYLATION, AND MITOCHONDRIAL FUNCTION, DYNAMICS, AND CONTENT
Luiz Silva, Amanda Siena, Jéssica Mayumi Camargo Yuzawa, et al.
Neuropharmacology (2025), pp. 110484-110484
Closed Access
Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients
C. González Mingot, F. MENA, Pedro Iñarrea, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3560-3560
Open Access | Times Cited: 7
Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases
Luis F. González, Lorenzo E. Bevilacqua, Rodrigo Naves
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2055-2055
Open Access | Times Cited: 16
Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis
Lanqi Li, Donghong Cai, Zhong Huiya, et al.
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 11
Mitochondria as the target for disease related hormonal dysregulation
Gladys A. Shaw
Brain Behavior & Immunity - Health (2021) Vol. 18, pp. 100350-100350
Open Access | Times Cited: 12
Neonatal Rotenone Administration Induces Psychiatric Disorder-Like Behavior and Changes in Mitochondrial Biogenesis and Synaptic Proteins in Adulthood
Amanda Siena, Jéssica Mayumi Camargo Yuzawa, Aline Camargo Ramos, et al.
Molecular Neurobiology (2021)
Closed Access | Times Cited: 11
Evidence of mitochondrial dysfunction in ALS and methods for measuring in model systems
James Lee, Natalie Pye, Laura V. Ellis, et al.
International review of neurobiology (2024), pp. 269-325
Closed Access | Times Cited: 1
Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases
Abdul Aziz Mohamed Yusoff, Siti Zulaikha Nashwa Mohd Khair
Reviews in the Neurosciences (2024)
Open Access | Times Cited: 1
Enhancing CNS mitophagy: drug development and disease-relevant models
K.L. Dhar, Brendan Townsend, Andrew P. Montgomery, et al.
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 1
The role of adiponectin-AMPK axis in TDP-43 mislocalization and disease severity in ALS
Yu‐Ju Liu, Cheng‐Chia Lee, Yi‐Chu Liao, et al.
Neurobiology of Disease (2024), pp. 106715-106715
Open Access | Times Cited: 1
Mitochondrial Aconitase enzymatic activity: a potential long survival biomarker in the blood of ALS patients
C. González Mingot, Francisco Javier Miana, Pedro Iñarrea, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 3
Overexpression of mTOR in Leukocytes from ALS8 Patients
Nathália Augusta Gomes, Francisco das Chagas Lima e Silva, Caroline Maria Oliveira Volpe, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 3, pp. 482-490
Open Access | Times Cited: 3
Ginsenoside-Rg1 combined with a conditioned medium from induced neuron-like hUCMSCs alleviated the apoptosis in a cell model of ALS through regulating the NF-κB/Bcl-2 pathway
Yu Huang, Huili YANG, Biying Yang, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 7, pp. 540-550
Closed Access | Times Cited: 3
Analysis of Mitochondrial Dysfunction by Microplate Reader in hiPSC-Derived Neuronal Cell Models of Neurodegenerative Disorders
Tatiana R. Rosenstock, Congxin Sun, Georgina W. Hughes, et al.
Methods in molecular biology (2022), pp. 1-21
Closed Access | Times Cited: 4
Redox profiles of amyotrophic lateral sclerosis lymphoblasts with or without known SOD1 mutations
Teresa Cunha‐Oliveira, Daniela Franco da Silva, Luis Segura, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 9
Closed Access | Times Cited: 4
Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints
Teresa Cunha‐Oliveira, Marcelo Carvalho, Vilma A. Sardão, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6373-6396
Closed Access | Times Cited: 4
Arylamine N-acetyltransferase-1 reveals a subpopulation of ALS patients with altered metabolic capacity
Chandra Choudhury, Sally Allen, Melinder K. Gill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Sirtuins Modulators Counteract Mitochondrial Dysfunction in Cellular Models of Hypoxia: Relevance to Schizophrenia
Luiz Silva, Amanda Siena, Jéssica Mayumi Camargo Yuzawa, et al.
Neuroscience (2023) Vol. 524, pp. 269-284
Closed Access | Times Cited: 1
Tracing ALS Degeneration: Insights from Spinal Cord and Cortex Transcriptomes
Nela Pragathi Sneha, S. Akila Parvathy Dharshini, Y‐h. Taguchi, et al.
Genes (2024) Vol. 15, Iss. 11, pp. 1431-1431
Open Access
Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints
Teresa Cunha‐Oliveira, Marcelo de Carvalho, Vilma A. Sardão, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top